Pharmaceutical

Bavarian Nordic seeks authorisation for mpox vaccine’s use in adolescents

Bavarian Nordic aims to gain a label expansion for adolescents in Europe in Q4 this year, whilst it prepares a trial in children in Africa.

Aug 17, 2024 - 04:00
Bavarian Nordic seeks authorisation for mpox vaccine’s use in adolescents
Bavarian Nordic aims to gain a label expansion for adolescents in Europe in Q4 this year, whilst it prepares a trial in children in Africa.
Read the original article

Tags:

Previous Article

AstraZeneca wins approval for Imfinzi in NSCLC perioperative setting

Next Article

Armed with Phase III win, Incyte eyes label expansion for Monjuvi

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

After FDA nod, Better Therapeutics races to boost dwindling cash

After FDA nod, Better Therapeutics races to boost dwind...

Jul 14, 2023

Listen: Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers

Listen: Illumina’s boardroom intrigue, the next big Alz...

Apr 7, 2023

FDA launches new rare disease innovation hub

FDA launches new rare disease innovation hub

Jul 20, 2024